Stock: OMCL. Includes companies and brands it has bought. Official US government data, updated September 2026.
510(k) clearances
1
De Novo: 0
PMA approvals
0
0 supplements
Recalled products
3
1 class I
Adverse event reports
59
- deaths reported
Omnicell has 3 recalled medical device products in 3 recall actions in the records, 1 of them class I (the most serious kind). The newest recall started on Mar 25, 2026. In 2025 it had 1 recalled products.
1 510(k) clearances, 0 De Novo grants and 0 original PMA approvals for high-risk devices, plus 0 PMA supplements (changes to approved devices). The newest decision was on Apr 24, 2022.
59 reports in total: - deaths, 3 injuries and 50 malfunctions were reported. 2 reports were received in 2025. A report alone does not show that the device caused the problem.
Last 15 years
| Year | 510(k) clearance | De Novo grant | PMA approval | PMA supplement |
|---|---|---|---|---|
| 2022 | 1 | 0 | 0 | 0 |
Recalled products, class I, and reports received
| Year | Recalls | Class I | Reports |
|---|
By product code, all years
All device makers and procedures · OMCL stock page
Official US government data on medical device marketing decisions, recalls (one row per recalled product) and adverse event reports. Company names in the records are linked to OMCL with a reviewed list that includes the companies it has bought. Adverse event reports come from makers, hospitals, doctors and patients; a report alone does not prove that a device caused the problem.
| Deaths |
|---|
| 2026 | 1 | 1 | 1 | - |
| 2025 | 1 | 0 | 2 | - |
| 2023 | 1 | 0 | 2 | - |
| 2022 | 0 | 0 | 3 | - |
| 2021 | 0 | 0 | 18 | - |
| 2020 | 0 | 0 | 25 | - |
| 2017 | 0 | 0 | 1 | - |
| 2016 | 0 | 0 | 2 | - |
| 2014 | 0 | 0 | 1 | - |